TY  - GEN
AU  - Cortes,J E
AU  - Kim,D-W
AU  - Pinilla-Ibarz,J
AU  - le Coutre,P
AU  - Paquette,R
AU  - Chuah,C
AU  - Nicolini,F E
AU  - Apperley,J F
AU  - Khoury,H J
AU  - Talpaz,M
AU  - DiPersio,J
AU  - DeAngelo,D J
AU  - Abruzzese,E
AU  - Rea,D
AU  - Baccarani,M
AU  - Müller,M C
AU  - Gambacorti-Passerini,C
AU  - Wong,S
AU  - Lustgarten,S
AU  - Rivera,V M
AU  - Clackson,T
AU  - Turner,C D
AU  - Haluska,F G
AU  - Guilhot,F
AU  - Deininger,M W
AU  - Hochhaus,A
AU  - Hughes,T
AU  - Goldman,J M
AU  - Shah,N P
AU  - Kantarjian,H
TI  - A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias
SN  - 1533-4406
PY  - 2013///1112
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - adverse effects
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Protein Kinase Inhibitors
KW  - Pyridazines
KW  - Thrombocytopenia
KW  - chemically induced
KW  - Thrombosis
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1306494
ER  -